Eli Lilly announced it planned to require 340B claims data reporting for in-house pharmacies beginning next month.

Lilly Announces Plan to Require 340B Claims Data for In-House Pharmacies

January 16, 2026 William Newton, Associate Editor/Senior Writer 340B Report Views

Pharmaceutical giant Eli Lilly has announced plans to require covered entities to report claims data for 340B drugs dispensed to [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!